An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Soiza, Roy L
De Brauwer, Isabelle
Coleman, Jamie J
MetadataShow full item record
CitationAnrys P, Petit AE, Thevelin S, et al. An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People. J Am Med Dir Assoc. 2021;22(10):2121-2133.e24. doi:10.1016/j.jamda.2021.03.019
AbstractObjectives: We aimed to establish an explicit list of potentially clinically significant drug-drug interactions (DDIs) in people aged ≥65 years. Design: A preliminary list of potentially clinically significant DDIs was compiled, based on 154 DDIs identified from literature review. Subsequently, a 2-round online Delphi survey was undertaken with a multidisciplinary expert panel. A consensus meeting and a final round were conducted to validate the final DDI list and the scope of information provided. Setting and participants: Twenty nine experts, including geriatricians and clinical pharmacists from 8 European countries. Measures: For each DDI, in the first 2 rounds, experts were asked to score the severity of potential harm on a 5-point Likert-type scale. DDIs were directly included on the final list if the median score was 4 (major) or 5 (catastrophic). DDIs with a median score of 3 (moderate) were discussed at a consensus meeting and included if ≥75% of participants voted for inclusion in the final round. Results: Consensus was achieved on 66 potentially clinically significant DDIs (28 had a median score of 4/5 and 48 of 3 in the Delphi survey). Most concerned cardiovascular, antithrombotic, and central nervous system drugs. The final list includes information on the mechanism of interaction, harm, and management. Treatment modification is recommended for three-quarters of DDIs. Conclusion and implications: We validated a list of potentially clinically significant DDIs in older people, which can be used in clinical practice and education to support identification and management of DDIs or to assess prevalence in epidemiologic and intervention studies. Keywords: Delphi technique; aged; drug interactions.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
RightsCopyright © 2021 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.
- Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
- Authors: Chan A, Tan SH, Wong CM, Yap KY, Ko Y
- Issue date: 2009
- Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.
- Authors: Bakker T, Klopotowska JE, de Keizer NF, van Marum R, van der Sijs H, de Lange DW, de Jonge E, Abu-Hanna A, Dongelmans DA, SIMPLIFY Study Group.
- Issue date: 2020 Jun
- The Norwegian General Practice--Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: A web-based Delphi study.
- Authors: Nyborg G, Straand J, Klovning A, Brekke M
- Issue date: 2015 Jun
- Consensus validation of the POSAMINO (POtentially Serious Alcohol-Medication INteractions in Older adults) criteria.
- Authors: Holton AE, Gallagher PJ, Ryan C, Fahey T, Cousins G
- Issue date: 2017 Nov 8
- Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial.
- Authors: Zerah L, Henrard S, Wilting I, O'Mahony D, Rodondi N, Dalleur O, Dalton K, Knol W, Haschke M, Spinewine A
- Issue date: 2021 Oct 18